PUBLIC COMPANY
saveAviceda Therapeutics Inc
updated 3mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Biopharma layoffs rise YOY in October but sharply trend down for 2026October marked the first time this year there was an increase in both the number of biotech and pharma companies trimming their workforces and the number of affected employees when compared to 2025…biospace · 8d ago
- J&J’s disappointing Q3, RevMed’s subgroup data, BMS’ ‘mixed’ results, Caribou’s cutbackJohnson & Johnson beat analyst expectations in the third quarter but left Wall Street wanting more; BMS dominated the news cycle on Monday with a Phase 3 win validating its $4.1 billion RayzeBio bu…biospace · 1mo ago
- 2 Massachusetts biotechs call it quitsAdecto Pharmaceuticals has ceased operations, while Aviceda Therapeutics is in the process of winding down.biospace · 1mo ago
- Geographic atrophy biotech Aviceda to shut down after Phase 2 failAviceda Therapeutics, a biotech that had planned to take an eye drug into Phase 3 this year despite a mid-stage clinical setback, is in the process of winding down, a source familiar with the decis…endpoints · 1mo ago
comments(0)
5-min edit window · permanent after that